ITC Confronts Divergent Views On Expanding COVID IP Deal
The U.S. International Trade Commission heard starkly different opinions Wednesday on a proposal to let developing countries override patents on COVID-19 treatments and tests, with drugmakers warning the move would chill...To view the full article, register now.
Already a subscriber? Click here to view full article